Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Efficacy and Safety of Cannabidiol for Anxiety: A Bibliometric Analysis and Systematic Review

Journal of Public Health and Pharmacy · Vol. 5 No. 3 (2025) · hlm. 645–663

DOI
10.56338/jphp.v5i3.6807
ISSN
2775-4952
Terbit
2025-10-02
Penerbit
Pusat Pengembangan Teknologi Informasi dan Jurnal Universitas Muhammadiyah Palu
Bahasa
eng

Abstrak

Introduction: A non-psychoactive substance present in the cannabis plant, cannabidiol (CBD), seems to have potential as an anxiolytic agent. This study systematically reviews the efficacy, safety, dosage, mechanisms, and adverse effects of CBD in treating anxiety. Methods: The PRISMA guideline was used to conduct the review. Results: A total of 64 articles were included in the study. It showed that CBD works at the endocannabinoid receptors CB1 and 5-HT1A, which regulate mood and reduce anxiety. In animal models, a range dosage of 5 – 10 mg/kg showed a significant anxiolytic effect in behavioral tests, while in humans, 300 mg/day was proven to be effective in treating various types of anxiety disorders. However, individual responses to CBD showed varying results, and demographic characteristics affect the efficacy of animal and human studies. CBD was also considered safer to be used in the short term compared to diazepam, although the long-term effect remains lacking evidence Conclusion: This study concludes that CBD has potential as an alternative choice for anxiety. Further research is needed in larger populations with rigorous study design and longer study durations to evaluate its effectiveness and ensure its safety. Recommendations for Future Research: It is hoped that future research can examine the effects of fly resistance and killing on non-target organisms and control environmental conditions.

Kata kunci

Jaringan kolaborasi para penulis

20 penulis · 72 tautan kepenulisan bersama · 16 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Udayana University
  • Warmadewa University
  • Universitas Bali Internasional
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Pande Putu JanuragaUdayana University1
Anak Agung Sagung SawitriUdayana University1
I Made Ady WirawanUdayana University1
Ni Wayan TianingUdayana University1
Ni Made Utami DwipayantiAfiliasi tidak diketahui1
Ni Made Swasti WulanyaniUdayana University1
Desak Putu Yuli KurniatiUdayana University1
Ni Luh Putu Rita PrimayuniUdayana University1
Ni Luh RustiniUdayana University1
Dewa Ayu Agus Sri LaksemiUdayana University1
Putu Ayu Asri DamayantiUdayana University1
I Made SudarmajaUdayana University1
I Ketut TunasUniversitas Bali Internasional1
Luh Putu Ratna SundariUdayana University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://jurnal.unismuhpalu.ac.id/index.php/jphp/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Efficacy and Safety of Cannabidiol for Anxiety: A Bibliometric Analysis and Systematic Review</dc:title>
	<dc:creator>Fajaryani, Putu Ayu Putri</dc:creator>
	<dc:creator>I Made Agus Gelgel Wirasuta</dc:creator>
	<dc:creator>Pande Made Nova Armita Sari</dc:creator>
	<dc:creator>Dyah Kanya Wati</dc:creator>
	<dc:creator>Putu Indah Budi Apsari</dc:creator>
	<dc:creator>Made Ary Sarasmita</dc:creator>
	<dc:subject xml:lang="en-US">Anxiety</dc:subject>
	<dc:subject xml:lang="en-US">Anxiolytic</dc:subject>
	<dc:subject xml:lang="en-US">Cannabidiol</dc:subject>
	<dc:subject xml:lang="en-US">Pharmacology</dc:subject>
	<dc:description xml:lang="en-US">Introduction: A non-psychoactive substance present in the cannabis plant, cannabidiol (CBD), seems to have potential as an anxiolytic agent. This study systematically reviews the efficacy, safety, dosage, mechanisms, and adverse effects of CBD in treating anxiety.
Methods: The PRISMA guideline was used to conduct the review.
Results: A total of 64 articles were included in the study. It showed that CBD works at the endocannabinoid receptors CB1 and 5-HT1A, which regulate mood and reduce anxiety. In animal models, a range dosage of 5 – 10 mg/kg showed a significant anxiolytic effect in behavioral tests, while in humans, 300 mg/day was proven to be effective in treating various types of anxiety disorders. However, individual responses to CBD showed varying results, and demographic characteristics affect the efficacy of animal and human studies. CBD was also considered safer to be used in the short term compared to diazepam, although the long-term effect remains lacking evidence
Conclusion: This study concludes that CBD has potential as an alternative choice for anxiety. Further research is needed in larger populations with rigorous study design and longer study durations to evaluate its effectiveness and ensure its safety.&amp;nbsp;
Recommendations for Future Research: It is hoped that future research can examine the effects of fly resistance and killing on non-target organisms and control environmental conditions.</dc:description>
	<dc:publisher xml:lang="en-US">Pusat Pengembangan Teknologi Informasi dan Jurnal Universitas Muhammadiyah Palu</dc:publisher>
	<dc:date>2025-10-02</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jurnal.unismuhpalu.ac.id/index.php/jphp/article/view/6807</dc:identifier>
	<dc:identifier>10.56338/jphp.v5i3.6807</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Public Health and Pharmacy; Vol. 5 No. 3 (2025); 645-663</dc:source>
	<dc:source>2775-4952</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jurnal.unismuhpalu.ac.id/index.php/jphp/article/view/6807/6025</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Journal of Public Health and Pharmacy</dc:rights>
</oai_dc:dc>